Assesment of New Devices for the Diagnostic Evaluation of Diaphragmatic Dysfunction (DYSDIA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03463798 |
|
Recruitment Status :
Recruiting
First Posted : March 13, 2018
Last Update Posted : July 23, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Diaphragmatic Paralysis Healthy Volunteers | Device: Sonar Device: Structured light plethysmography (SLP) |
The measurements of chest and abdominal wall movements during quiet tidal breathing will be performed simultaneously using SLP and Sonar devices.
Subjects will be asked to sit down on a chair with their neck in a neutral position and their back as straight as possible. The SLP and the Sonar will be lined up to project the grid of light and the ultrasonic wave sonar over the participant's chest and abdomen. Data will be collected during 5 minutes of tidal breathing. The same procedure will be repeated while having the patient lying down in supine position on the same chair for 5 additional minutes. During both sessions (sitting and supine), patients will be asked to perform a gentle inspiratory capacity (IC) maneuver to better appreciate the thoraco-abdominal asymmetry and distortion.
| Study Type : | Observational |
| Estimated Enrollment : | 180 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Assesment of New Devices for the Diagnostic Evaluation of Diaphragmatic Dysfunction |
| Actual Study Start Date : | June 11, 2018 |
| Estimated Primary Completion Date : | January 30, 2033 |
| Estimated Study Completion Date : | June 11, 2033 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients
Patients with a suspicion of diaphragmatic dysfunction
|
Device: Sonar
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly Device: Structured light plethysmography (SLP) Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly |
|
Healthy volunteers
Subjects without any medical condition
|
Device: Sonar
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly Device: Structured light plethysmography (SLP) Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly |
- amplitude of displacement of thoraco-abdominal compartments [ Time Frame: 10 minutes ]asymmetry of displacement of thoraco-abdominal compartments during tidal breathing and respiratory manoeuvres
- displacement speed of thoraco-abdominal compartments [ Time Frame: 10 minutes ]asynchrony of displacement of thoraco-abdominal compartments during tidal breathing and respiratory manoeuvres measurement
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
FOR HEALTHY VOLUNTEERS
Inclusion Criteria:
- no respiratory disease
- no neurologic disease
- no thoracic deformation
Exclusion criteria
- respiratory disease
- neurologic disease
- thoracic deformation
FOR PATIENTS
Inclusion Criteria:
- patients with a suspicion of diaphragmatic dysfunction
Exclusion Criteria:
- pregnant women
- contraindications to standard procedure requiring transdiaphragmatic measurement
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03463798
| Contact: Marie-Cécile NIERAT, phD | 0142178196 | m-cecile.nierat@wanadoo.fr |
| France | |
| INSERM-UPC UMR_S 1158 Service de Pneumologie et Réanimation, R3S, Groupe Hospitalier Pitié-Salpêtrière | Recruiting |
| Paris, France, 75013 | |
| Contact: Marie-Cécile Niérat, PhD 0142178196 ext 0033 m-cecile.nierat@wanadoo.fr | |
| Contact: Sophie Lavault, PhD 0142178196 ext 0033 sophie.lavault@aphp.fr | |
| Sub-Investigator: Capucine Morelot-Panzini, MD, PhD | |
| Sub-Investigator: Christian Straus, MD, PhD | |
| Sub-Investigator: Claudia Llontop, MD | |
| Principal Investigator: Pierantonio Laveneziana, MD, PhD | |
| Sub-Investigator: Marie-Cécile Niérat, PhD | |
| Sub-Investigator: Thomas Similowski, MD,PhD | |
| Principal Investigator: | Pierantonio LAVENEZIANA, MD, PhD | UMRS_1158 |
| Responsible Party: | Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil |
| ClinicalTrials.gov Identifier: | NCT03463798 |
| Other Study ID Numbers: |
2017-A03665-48 |
| First Posted: | March 13, 2018 Key Record Dates |
| Last Update Posted: | July 23, 2021 |
| Last Verified: | July 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
structured light plethysmography sonar transdiaphragmatic pressure |
|
Respiratory Paralysis Paralysis Neurologic Manifestations Nervous System Diseases |
Respiratory Insufficiency Respiration Disorders Respiratory Tract Diseases |

